Source:http://linkedlifedata.com/resource/pubmed/id/11004846
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3-4
|
| pubmed:dateCreated |
2000-11-13
|
| pubmed:abstractText |
The aim of the study was to evaluate the concentrations of bFGF and VEGF in double BAL (2 x 120 ml) from two different lung segments: (s.A) from upper lobe with the most and (s.B) from lower lobe with the least extensive involvement estimated by high resolution computed tomography (HRCT). Examined group consisted of 28 sarcoid patients with homogeneous, regular distribution of nodular opacities in conventional chest X-ray (14 F, 14 M aged 19-54). Eleven healthy volunteers served as controls. In patients with sarcoidosis we observed the significantly higher levels (p < 0.01) of bFGF (1.79 pg/ml, 1.48 pg/ml) and VEGF (107.5 pg/ml, 109.7 pg/ml) in BAL from s.A and s.B respectively in comparison with BAL from lung segments Abis and Bbis in control group (bFGF: 0.75 pg/ml, 0.47 pg/ml and VEGF: 33.7 pg/ml, 43.9 pg/ml respectively). bFGF in BAL from s.A in active sarcoidosis was higher than in s.A and s.B in non-active sarcoidosis. Concentrations of bFGF in BAL from both s.A and s.B correlated positively with CD4/CD8 ratio and absolute number of lymphocytes, CD4 cells and lymphocytes HLA-DR estimated in BAL from these lung segments. We conclude that bFGF and VEGF may be involved in sarcoidosis pathogenesis and bFGF may be useful in estimation of sarcoidosis activity.
|
| pubmed:language |
pol
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0867-7077
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
68
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
120-30
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11004846-Adult,
pubmed-meshheading:11004846-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:11004846-CD4-CD8 Ratio,
pubmed-meshheading:11004846-Cell Count,
pubmed-meshheading:11004846-Endothelial Growth Factors,
pubmed-meshheading:11004846-Female,
pubmed-meshheading:11004846-Fibroblast Growth Factor 2,
pubmed-meshheading:11004846-Humans,
pubmed-meshheading:11004846-Lung,
pubmed-meshheading:11004846-Lymphocyte Count,
pubmed-meshheading:11004846-Lymphokines,
pubmed-meshheading:11004846-Male,
pubmed-meshheading:11004846-Middle Aged,
pubmed-meshheading:11004846-Radiographic Image Enhancement,
pubmed-meshheading:11004846-Sarcoidosis, Pulmonary,
pubmed-meshheading:11004846-Tomography, X-Ray Computed,
pubmed-meshheading:11004846-Vascular Endothelial Growth Factor A,
pubmed-meshheading:11004846-Vascular Endothelial Growth Factors
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
[Proangiogenic cytokines (bFGF and VEGF) in BALF from two different lung segments examined by high resolution computed tomography (HRCT) in patients with sarcoidosis].
|
| pubmed:affiliation |
Kliniki Ftizjopneumonologii Sl.A.M. w Zabrzu.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Controlled Clinical Trial
|